Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8285254rdf:typepubmed:Citationlld:pubmed
pubmed-article:8285254lifeskim:mentionsumls-concept:C0028040lld:lifeskim
pubmed-article:8285254lifeskim:mentionsumls-concept:C0441833lld:lifeskim
pubmed-article:8285254lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:8285254lifeskim:mentionsumls-concept:C0232338lld:lifeskim
pubmed-article:8285254lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:8285254lifeskim:mentionsumls-concept:C0205146lld:lifeskim
pubmed-article:8285254lifeskim:mentionsumls-concept:C0439830lld:lifeskim
pubmed-article:8285254lifeskim:mentionsumls-concept:C0806140lld:lifeskim
pubmed-article:8285254pubmed:issue6 Pt 2lld:pubmed
pubmed-article:8285254pubmed:dateCreated1994-2-14lld:pubmed
pubmed-article:8285254pubmed:abstractTextTo examine the mechanism of local cerebral blood flow (LCBF) elevation, nicotine (1.75 mg/kg sc) was administered to rats, and LCBF plus the distribution spaces of radiolabeled albumin (RISA) and red blood cells (RBC) in parenchymal microvessels were measured throughout the brain. Microvascular blood spaces and transit times were calculated from the data. From 1.5 to 3 min after nicotine administration, LCBF was raised by 40-150% in 16 of the brain areas and unaltered in the remaining 28 areas. The affected structures included parts of the visual-auditory, sensorimotor-cortical, and interpeduncular systems. RBC spaces were not changed by nicotine treatment. RISA and blood spaces were increased slightly but not significantly in some of the LCBF-affected areas but nowhere else. Nicotine seemingly elevates LCBF in the affected areas mainly by increasing linear velocity of flow through the microvascular beds. In agreement with this, mean transit time, which is inversely related to velocity, was decreased from 0.3-0.5 to approximately 0.2 s in the microvascular systems of the nicotine-affected areas.lld:pubmed
pubmed-article:8285254pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8285254pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8285254pubmed:languageenglld:pubmed
pubmed-article:8285254pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8285254pubmed:citationSubsetIMlld:pubmed
pubmed-article:8285254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8285254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8285254pubmed:statusMEDLINElld:pubmed
pubmed-article:8285254pubmed:monthDeclld:pubmed
pubmed-article:8285254pubmed:issn0002-9513lld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:OtsukaTTlld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:ChenJ LJLlld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:WegNNlld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:PatlakCClld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:Fenstermacher...lld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:AcuffVVlld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:BereczkiDDlld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:HansF JFJlld:pubmed
pubmed-article:8285254pubmed:authorpubmed-author:DemaroJJlld:pubmed
pubmed-article:8285254pubmed:issnTypePrintlld:pubmed
pubmed-article:8285254pubmed:volume265lld:pubmed
pubmed-article:8285254pubmed:ownerNLMlld:pubmed
pubmed-article:8285254pubmed:authorsCompleteYlld:pubmed
pubmed-article:8285254pubmed:paginationH2142-50lld:pubmed
pubmed-article:8285254pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:meshHeadingpubmed-meshheading:8285254-...lld:pubmed
pubmed-article:8285254pubmed:year1993lld:pubmed
pubmed-article:8285254pubmed:articleTitleNicotine increases microvascular blood flow and flow velocity in three groups of brain areas.lld:pubmed
pubmed-article:8285254pubmed:affiliationDepartment of Neurological Surgery, State University of New York, Stony Brook 11794-8122.lld:pubmed
pubmed-article:8285254pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8285254pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8285254lld:pubmed